Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Published:2019-04-10 Issue:1 Volume:18 Page:
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Mol Cancer

Author:

Xu Ke,Park Dongkyoo,Magis Andrew T.,Zhang Jun,Zhou Wei,Sica Gabriel L.,Ramalingam Suresh S.,Curran Walter J.,Deng Xingming

Funder

National Cancer Institute

National Institute of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12943-019-1012-4.pdf

Reference60 articles.

1. Overmeyer JH, Maltese WA. Death pathways triggered by activated Ras in cancer cells. Front Biosci (Landmark Ed). 2011;16:1693–713.

2. Hancock JF. Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol. 2003;4:373–84.

3. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3:11–22.

4. Stephen AG, Esposito D, Bagni RK, McCormick F. Dragging ras back in the ring. Cancer Cell. 2014;25:272–81.

5. Cox AD, Fesik SW, Kimmelman AC, Luo J, Der CJ. Drugging the undruggable RAS: Mission possible? Nat Rev Drug Discov. 2014;13:828–51.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway;Biomedicine & Pharmacotherapy;2024-07

2. Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses;Frontiers in Pharmacology;2024-06-14

3. Enhancing oncogenic signaling to kill cancer cells;Trends in Pharmacological Sciences;2024-06

4. Targeting KRASG12D mutation in non-small cell lung cancer: molecular mechanisms and therapeutic potential;Cancer Gene Therapy;2024-05-11

5. Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target;BMC Chemistry;2024-03-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3